Airway Metalloproteinases in Mucosal Immunity
Airway Metalloproteinases in Mucosal Immunity
批准号:
7851276
负责人:
WILLIAM C PARKS
金额:
$24.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-05 至 2012-05-31
关键词:
AirAlveolarAnimalsAnti-Bacterial AgentsBacteriaBacterial InfectionsBacterial PneumoniaBiochemicalCellsChronicCommunity-Acquired InfectionsCoughingCystic FibrosisDataDefense MechanismsDefensinsDevelopmentDisease modelElevatorEpithelialEpithelial CellsExcisionExposure toFlagellinFoundationsFutureGasesGene FamilyGenerationsGoalsHaemophilus influenzaeHealthHost DefenseImmunityInfectionInflammationInfluenzaInjuryLiquid substanceLungMatrilysinMatrix MetalloproteinasesMediatingMetalloproteasesMetalloproteinase GeneModelingMorbidity - disease rateMucosal ImmunityMucous MembraneMuramidaseMusNatural ImmunityNatureOrganPatientsPlayPredispositionProductionProtein PrecursorsProteinsProteolysisPseudomonas aeruginosaPublishingResearch Project GrantsRespirationRoleStaphylococcus aureusStructure of parenchyma of lungSurfaceVentilatorairway epitheliumantimicrobial drugbasecystic fibrosis patientsin vivoinsightmembermicroorganismmortalitymouse modelneutrophilnovelpathogenrepairedrespiratoryresponse
中文摘要
描述(由申请方提供):铜绿假单胞菌引起的肺部慢性感染是囊性纤维化患者发病和死亡的主要原因。已经提出了许多假设来解释这些患者长期被这种微生物定植的倾向,其中许多假设意味着气道上皮的防御机制有缺陷。基质溶素是一种基质金属蛋白酶(MMP),在先天免疫中起作用,并促进上皮再生和中性粒细胞流入。基质溶素在感染的肺中显著表达,并且通过暴露于细菌或细菌产物(特别是铜绿假单胞菌鞭毛蛋白)在上皮细胞中诱导。我们假设基质溶解素是呼吸道粘膜先天防御的关键参与者,通过前体蛋白的蛋白水解产生抗菌活性。事实上,R21应用的初步数据表明,来自未处理基质溶素缺失(Mmp 7-/-)小鼠的气道液中的非防御素抗菌活性明显不足,并且这种活性的大小估计表明它是一种新的因子。此外,这种活性在野生型小鼠中响应于铜绿假单胞菌感染而显著上调,但在Mmp 7-/-肺中仍然缺乏。为了研究该MMP在肺免疫中的作用,我们计划:1)分离和表征肺中的基质溶解素依赖性抗菌剂;和2)验证基质溶解素在防御铜绿假单胞菌感染中的作用。这些研究将为了解基质溶解素在粘膜防御机制中的作用提供重要的信息。
各种病原体引起的肺部感染(例如,金黄色葡萄球菌、流感嗜血杆菌、铜绿假单胞菌等)是囊性纤维化和通气患者社区获得性感染以及发病率和死亡率的主要原因。我们假设基质溶解素通过前体蛋白的蛋白水解产生抗菌活性,在呼吸道粘膜先天防御中发挥关键作用。这些研究将为了解基质溶解素在粘膜防御机制中的作用提供重要的信息。
英文摘要
DESCRIPTION (provided by applicant): Chronic infection of the lung by Pseudomonas aeruginosa is the major cause of morbidity and mortality in patients with cystic fibrosis. A number of hypotheses have been proposed to explain the predisposition of these patients to prolonged colonization by this microorganism, many of which imply defective defense mechanisms of the airway epithelium. Matrilysin, a matrix metalloproteinase (MMP), functions in innate immunity and facilitates re-epithelialization and neutrophil influx. Matrilysin is markedly expressed in infected lungs and is induced in epithelial cells by exposure to bacteria or bacterial products, specifically P. aeruginosa flagellin. We hypothesize that matrilysin is a key player in respiratory mucosal innate defense by generating an antibacterial activity via proteolysis of a precursor protein. Indeed, preliminary data for this R21 application demonstrates a marked deficiency in non-defensin antibacterial activity in airway fluid from na¿ve matrilysin-null (Mmp7-/-) mice, and size estimates of this activity suggest that it is a novel factor. Furthermore, this activity is markedly upregulated in wildtype mice in response to P. aeruginosa infection, yet remains deficient in Mmp7-/- lung. To investigate the role of this MMP in lung immunity, we plan to: 1) isolate and characterize the matrilysin- dependent antibacterial in lung; and 2) verify the role of matrilysin in defense against P. aeruginosa infection. These studies will provide important insight into the role of matrilysin in mucosal defense mechanisms.
Infection of the lung by various pathogens (e.g., Staphylococcus aureus, haemophilus influenzae, Pseudomonas aeruginosa, and other) are a major cause of community-acquired infection and morbidity and mortality in cystic fibrosis and ventilated patients. We hypothesize that matrilysin is a key player in respiratory mucosal innate defense by generating an antibacterial activity via proteolysis of a precursor protein. These studies will provide important insight into the role of matrilysin in mucosal defense mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Macrophage Activation in Lung Disease
-
批准号:9898443
-
项目类别:
-
资助金额:$60.35万
-
财政年份:2018
-
负责人:WILLIAM C PARKS
-
依托单位:
Graduate Program in Biomedical Sciences and Translational Medicine
-
批准号:9974523
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2017
-
负责人:WILLIAM C PARKS
-
依托单位:
Graduate Program in Biomedical Sciences and Translational Medicine
-
批准号:10202636
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:WILLIAM C PARKS
-
依托单位:
Role of MMP10 in Macrophage Activation
-
批准号:9130372
-
项目类别:
-
资助金额:$53.99万
-
财政年份:2015
-
负责人:WILLIAM C PARKS
-
依托单位:
MMP10 Control of Macrophage Activation in COPD
-
批准号:8064157
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2011
-
负责人:WILLIAM C PARKS
-
依托单位:
MMP10 Control of Macrophage Activation in COPD
-
批准号:8584308
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2011
-
负责人:WILLIAM C PARKS
-
依托单位:
MMP10 Control of Macrophage Activation in COPD
-
批准号:8385535
-
项目类别:
-
资助金额:$41.29万
-
财政年份:2011
-
负责人:WILLIAM C PARKS
-
依托单位:
MMP10 Control of Macrophage Activation in COPD
-
批准号:8208108
-
项目类别:
-
资助金额:$43.13万
-
财政年份:2011
-
负责人:WILLIAM C PARKS
-
依托单位:
Regulation of Matrilysin Catalysis
-
批准号:8147486
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2010
-
负责人:WILLIAM C PARKS
-
依托单位:
Role of Stromelysin 2 (MMP-10) in Lung Immunity
-
批准号:8005421
-
项目类别:
-
资助金额:$50.27万
-
财政年份:2010
-
负责人:WILLIAM C PARKS
-
依托单位:
Airway Metalloproteinases in Mucosal Immunity
-
批准号:7701521
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2009
-
负责人:WILLIAM C PARKS
-
依托单位:
American Society fo Matrix Biology 2008
-
批准号:7614566
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2008
-
负责人:WILLIAM C PARKS
-
依托单位:
Epithelial control of Neutrophil Activation
-
批准号:7430309
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2007
-
负责人:WILLIAM C PARKS
-
依托单位:
Epithelial control of Neutrophil Activation
-
批准号:7810708
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2007
-
负责人:WILLIAM C PARKS
-
依托单位:
Epithelial control of Neutrophil Activation
-
批准号:7259016
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2007
-
负责人:WILLIAM C PARKS
-
依托单位:
Epithelial control of Neutrophil Activation
-
批准号:7595836
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2007
-
负责人:WILLIAM C PARKS
-
依托单位:
Epithelial MMPs in Airway Repair
-
批准号:7082083
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2004
-
负责人:WILLIAM C PARKS
-
依托单位:
Dermatology Training Grant
-
批准号:6750298
-
项目类别:
-
资助金额:$23.96万
-
财政年份:2004
-
负责人:WILLIAM C PARKS
-
依托单位:
Epithelial MMPs in Airway Repair
-
批准号:7251785
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2004
-
负责人:WILLIAM C PARKS
-
依托单位:
Epithelial MMPs in Airway Repair
-
批准号:7450969
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2004
-
负责人:WILLIAM C PARKS
-
依托单位:
海外基金